A case-control study of the clinical diagnosis and course of Lassa fever - PubMed (original) (raw)
A case-control study of the clinical diagnosis and course of Lassa fever
J B McCormick et al. J Infect Dis. 1987 Mar.
Abstract
A prospective case-control study of Lassa fever was established in Sierra Leone to measure the frequency and case-fatality ratio of Lassa fever among febrile hospital admissions and to better delineate the clinical diagnosis and course of this disease. Lassa fever was responsible for 10%-16% of all adult medical admissions and for approximately 30% of adult deaths in the two hospitals studied. The case-fatality ratio for 441 hospitalized patients was 16.5%. We found the best predictor of Lassa fever to be the combination of fever, pharyngitis, retrosternal pain, and proteinuria (predictive value together, .81); of outcome, the best predictor was the combination of fever, sore throat, and vomiting (relative risk of death, 5.5). Complications included mucosal bleeding (17%), bilateral or unilateral eighth-nerve deafness (4%), and pleural (3%) or pericardial (2%) effusion. Lassa fever is endemic in this area and is a more-common cause of hospital admission and death than has previously been described; this disease must be considered when diagnosing febrile illness in West Africa.
Similar articles
- Lassa fever in children in Sierra Leone, West Africa.
Webb PA, McCormick JB, King IJ, Bosman I, Johnson KM, Elliott LH, Kono GK, O'Sullivan R. Webb PA, et al. Trans R Soc Trop Med Hyg. 1986;80(4):577-82. doi: 10.1016/0035-9203(86)90147-1. Trans R Soc Trop Med Hyg. 1986. PMID: 3810792 - Lassa Fever Natural History and Clinical Management.
Grant DS, Samuels RJ, Garry RF, Schieffelin JS. Grant DS, et al. Curr Top Microbiol Immunol. 2023;440:165-192. doi: 10.1007/82_2023_263. Curr Top Microbiol Immunol. 2023. PMID: 37106159 - Lassa fever in post-conflict sierra leone.
Shaffer JG, Grant DS, Schieffelin JS, Boisen ML, Goba A, Hartnett JN, Levy DC, Yenni RE, Moses LM, Fullah M, Momoh M, Fonnie M, Fonnie R, Kanneh L, Koroma VJ, Kargbo K, Ottomassathien D, Muncy IJ, Jones AB, Illick MM, Kulakosky PC, Haislip AM, Bishop CM, Elliot DH, Brown BL, Zhu H, Hastie KM, Andersen KG, Gire SK, Tabrizi S, Tariyal R, Stremlau M, Matschiner A, Sampey DB, Spence JS, Cross RW, Geisbert JB, Folarin OA, Happi CT, Pitts KR, Geske FJ, Geisbert TW, Saphire EO, Robinson JE, Wilson RB, Sabeti PC, Henderson LA, Khan SH, Bausch DG, Branco LM, Garry RF; Viral Hemorrhagic Fever Consortium. Shaffer JG, et al. PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748. doi: 10.1371/journal.pntd.0002748. eCollection 2014 Mar. PLoS Negl Trop Dis. 2014. PMID: 24651047 Free PMC article. - Lassa fever in West African sub-region: an overview.
Ogbu O, Ajuluchukwu E, Uneke CJ. Ogbu O, et al. J Vector Borne Dis. 2007 Mar;44(1):1-11. J Vector Borne Dis. 2007. PMID: 17378212 Review. - Laboratory Diagnosis of Lassa Fever.
Raabe V, Koehler J. Raabe V, et al. J Clin Microbiol. 2017 Jun;55(6):1629-1637. doi: 10.1128/JCM.00170-17. Epub 2017 Apr 12. J Clin Microbiol. 2017. PMID: 28404674 Free PMC article. Review.
Cited by
- Seroprevalence and risk factors for Lassa virus infection in South-West and North-Central Nigeria: a community-based cross-sectional study.
Tiamiyu AB, Adegbite OA, Freides O, Frndak S, Mohammed SS, Broach E, Lombardi K, Anyebe V, Akiga R, Okeke NC, Feyisayo JE, Ugwuezumba O, Akinde C, Osuji A, Agu N, Analogbei T, Ekweremadu C, Bartolanzo D, Prins P, Fan Y, Emekaili D, Abah F, Chiwetelu V, Dike P, Isaiah E, Ayogu M, Ogunkelu E, Agbaim UC, Bukunmi A, Adamu Y, Mebrahtu T, Zuppe A, Johnston M, Modjarrad K, Meri H, Parker Z, Akinwale E, McCauley MD, Schluck G, King DB, Eller LA, Okeji N, Ayemoba OR, Collins ND, Iroezindu MO, Hakre S; EID023 Lassa study team. Tiamiyu AB, et al. BMC Infect Dis. 2024 Oct 8;24(1):1118. doi: 10.1186/s12879-024-09954-1. BMC Infect Dis. 2024. PMID: 39375602 Free PMC article. - Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses.
Brouwer PJM, Perrett HR, Beaumont T, Nijhuis H, Kruijer S, Burger JA, Bontjer I, Lee WH, Ferguson JA, Schauflinger M, Müller-Kräuter H, Sanders RW, Strecker T, van Gils MJ, Ward AB. Brouwer PJM, et al. Cell Rep. 2024 Sep 24;43(9):114708. doi: 10.1016/j.celrep.2024.114708. Epub 2024 Sep 6. Cell Rep. 2024. PMID: 39243373 Free PMC article. - The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics.
Bourner J, Salam AP, Jaspard M, Olayinka A, Fritzell C, Goncalves B, Vaillant M, Edwards T, Erameh C, Ajayi N, Ramharter M, Olliaro P; WALC Work Package 2 Working Group. Bourner J, et al. Wellcome Open Res. 2023 Jun 2;8:122. doi: 10.12688/wellcomeopenres.19041.2. eCollection 2023. Wellcome Open Res. 2023. PMID: 39211525 Free PMC article. - Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.
Kotliar D, Raju S, Tabrizi S, Odia I, Goba A, Momoh M, Sandi JD, Nair P, Phelan E, Tariyal R, Eromon PE, Mehta S, Robles-Sikisaka R, Siddle KJ, Stremlau M, Jalloh S, Gire SK, Winnicki S, Chak B, Schaffner SF, Pauthner M, Karlsson EK, Chapin SR, Kennedy SG, Branco LM, Kanneh L, Vitti JJ, Broodie N, Gladden-Young A, Omoniwa O, Jiang PP, Yozwiak N, Heuklom S, Moses LM, Akpede GO, Asogun DA, Rubins K, Kales S, Happi AN, Iruolagbe CO, Dic-Ijiewere M, Iraoyah K, Osazuwa OO, Okonkwo AK, Kunz S, McCormick JB, Khan SH, Honko AN, Lander ES, Oldstone MBA, Hensley L, Folarin OA, Okogbenin SA, Günther S, Ollila HM, Tewhey R, Okokhere PO, Schieffelin JS, Andersen KG, Reilly SK, Grant DS, Garry RF, Barnes KG, Happi CT, Sabeti PC. Kotliar D, et al. Nat Microbiol. 2024 Mar;9(3):751-762. doi: 10.1038/s41564-023-01589-3. Epub 2024 Feb 7. Nat Microbiol. 2024. PMID: 38326571 Free PMC article. - Alternative translation contributes to the generation of a cytoplasmic subpopulation of the Junín virus nucleoprotein that inhibits caspase activation and innate immunity.
Bostedt L, Fénéant L, Leske A, Holzerland J, Günther K, Waßmann I, Bohn P, Groseth A. Bostedt L, et al. J Virol. 2024 Feb 20;98(2):e0197523. doi: 10.1128/jvi.01975-23. Epub 2024 Jan 31. J Virol. 2024. PMID: 38294249 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources